Building Competency in Diabetes Education THE ESSENTIALS

BASAL-BOLUS INSULIN THERAPY | 12-113 115. Weisman A, Bai JW, Cardinez M, Kramer CK, Perkins BA. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol. 2017;5(7):501–12. 116. Bekiari E, Kitsios K, Thabit H, Tauschmann M, Athanasiadou E, Karagiannis T, Haidich AB, Hovorka R, Tsapas A. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ. 2018;18(361):k1310. 117. Pease A, Lo C, Earnest A. et al. Time in Range for Multiple Technologies in Type 1 Daibetes: a systematic Review and Network Meta-analysis. Diabetes Care 2020;43:1967-1975 118. Boscari 2021, Boscari F, Avogaro A. Current treatment options and challenges in patients with type1 diabetes” Pharmacological, technological advances and perspective. Rev endocrine Metab Disord 2021;22:217-240 119. Garg SK, Weinzimer SA, Tamborlane WV, et al. Glucose Outcomes with the In-Home Use off a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes. Diabetes Technol Ther.2017;19:155–163. 120. Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada: Appendix 9: Examples of insulin initiation and titration regimens in people with type 2 diabetes. Can J Diabetes 2018;42(Suppl 1):S317-S318. 121. Wolpert H, ed. Smart Pumping for People with Diabetes. Alexandria, VA: American Diabetes Association, 2002. 122. Hirsch IB, Farkas-Hirsch R. Sliding scale or sliding scare: It’s all sliding nonsense. Diabetes Spectr 2001;1:79-81. 123. Walsh J, Roberts R. Pumping Insulin. San Diego, CA: Torrey Pines Press, 2006. 124. Pearson J, Bergenstal R. Fine-tuning control: Pattern management versus supplementation. Diabetes Spectr 2001;14:75-8. 125. McGowan K, Thomas W, Moran A. Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care. 2002;25:1499- 503. 126. Monsod T, Flanagan D, Rife F, et al. Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care. 2002;25:889-93.